The Company

Lumigenex:Global Leader in Poct with TRFIA

Lumigenex is a fast growing biotechnology company dedicated to the development of proprietary technologies that meet the ever increasing demands on infection control and clinical diagnostics. We are applying our expertise in microencapsulation to develop new generation products for hygiene and infection control. Another area of our focus is on developing, establishing and validating next generation cost effective rapid diagnostic technologies and products over the coming years and beyond with our primary areas of interests in cardiology, women's health, infectious disease, oncology and drugs of abuse. 

Closely collaborating with our global strategic partners, we are committed to becoming a leading supplier of IVD products. We are also committed to providing superior customer service on demand by speedy delivery of solutions and products with uncompromised high quality.


To provide total diagnostic solutions for acute or chronic diseases across the lifespan of human beings anywhere anytime.


To become and be recognized as an indispensable partner in the advancement of human well-being, hygiene and health.

Mar. 2014

CFDA approvals for five immunoassay reagents adaptable to most chemical analyzers were obtained

Feb. 2014

CFDA approvals for time-resolved fluorescence immunochromatographic analyzer were obtained

Sep. 2013

Lumigenex passed The first Food and Drug Administration by the Suzhou Municipal Quality Management System Assessment